Actively Recruiting
Led by McGill University · Updated on 2025-07-31
300
Participants Needed
12
Research Sites
65 weeks
Total Duration
M
McGill University
Lead Sponsor
T
The University of New South Wales
Collaborating Sponsor
This research aims to understand how to expand point-of-care testing for hepatitis C virus (HCV) among key populations in Canada. It focuses on mapping current HCV care processes, identifying challenges and supports for implementing point-of-care testing, and collaborating with stakeholders to develop practical tools and strategies. The study is observational and seeks to provide evidence to guide the future adoption and sustainability of rapid HCV testing and treatment in various settings. The study involves observing existing clinical care without directly implementing point-of-care HCV testing. It includes participants from different groups: individuals at risk of HCV or attending related service sites, service providers and managers working at HCV service sites, policymakers involved in HCV testing and treatment planning, and laboratory or quality assurance professionals overseeing point-of-care testing. The research explores the feasibility, acceptability, and costs related to the use of rapid antibody and RNA tests for hepatitis C. Participants will provide insights through surveys and interviews about current HCV care, barriers and facilitators to point-of-care testing, and strategies to improve testing delivery. The study will measure outcomes like barriers and facilitators based on implementation science frameworks, acceptability and feasibility of testing strategies, and sustainability through cost analysis over one year. The involvement period varies depending on participant roles, with data collected to inform future efforts to scale up hepatitis C testing and treatment nationally.
CONDITIONS
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single visit
Participants undergo point-of-care hepatitis C antibody and RNA testing to diagnose current or past infection.
1 visit (in-person)
Duration - Up to 1 year
Participants are observed over time to identify barriers and facilitators to point-of-care hepatitis C testing and treatment, and to assess the acceptability, feasibility, and sustainability of testing strategies.
Periodic visits depending on participant role and cohort
Total: 12 locations
1
Anonyme L'Unite D'Intervention
Montreal, Quebec, Canada, H1N 1W2
Actively Recruiting
2
McGill University
Montreal, Quebec, Canada, H3S 1L8
Active, Not Recruiting
3
Indigenous Health Centre of Tiohtià:ke
Montreal, Quebec, Canada
Not Yet Recruiting
4
L'Anonyme
Montreal, Quebec, Canada
Actively Recruiting
5
Centre de réadaptation en dépendance de Québec (CRDQ)
Québec, Quebec, Canada
Not Yet Recruiting
6
Medicins du Monde
Montreal, Canada
Not Yet Recruiting
7
Okanagan prison
Okanagan, Canada
Not Yet Recruiting
8
SABSA Cooperative
Québec, Canada
Not Yet Recruiting
9
Sioux Lookout First Nation Health Authority
Sioux Lookout, Canada
Not Yet Recruiting
10
Ontario - Provincial correction
Toronto, Canada
Not Yet Recruiting
11
Rapid Access Addiction Clinic St Paul's Hospital
Vancouver, Canada
Not Yet Recruiting
12
Maamwesying North Shore Community Health Services
Wawa, Canada
Not Yet Recruiting
M
Meagan Mooney, RN, MA, BSc
C
Charlene Weight, MSc, BSc
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Meagan Mooney, Charlene Weight, Mia J Biondi...
https://pubmed.ncbi.nlm.nih.gov/41408357